Nektar Therapeutics
NKTR
NKTR
139 hedge funds and large institutions have $1.18B invested in Nektar Therapeutics in 2013 Q2 according to their latest regulatory filings, with 139 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
139
Holders Change
+139
Holders Change %
–
% of All Funds
4.54%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
139
Increased
–
Reduced
–
Closed
–
Calls
$12.7M
Puts
$1.62M
Net Calls
+$11.1M
Net Calls Change
+$11.1M
Top Buyers
1 |
O
1
OppenheimerFunds
New York
|
$262M |
2 |
2
Primecap Management
Pasadena,
California
|
$87.5M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$78.8M |
4 |
4
Federated Hermes
Pittsburgh,
Pennsylvania
|
$72.2M |
5 |
HM
5
HealthCor Management
New York
|
$46.2M |
Top Sellers
No sellers this quarter